Upcoming VRTX earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
November 2, 2026
Vertex Pharmaceuticals is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Vertex Pharmaceuticals reported a 12.5% revenue increase in Q2 FY2026 driven by its cystic fibrosis franchise and strong early sales of new therapies CASGEVY…
Vertex Pharmaceuticals delivered a strong Q1 FY2026 with revenue of $2.99B (+7.8% YoY), operating income surging 80.6% to $1.14B, and net income jumping 59.6%…
Vertex Pharmaceuticals delivered a strong FY2025 with revenue of $12.0B (+8.9% YoY) and a dramatic swing to profitability, posting net income of $3.95B versus…
Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on November 2, 2026, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Vertex Pharmaceuticals's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on August 4, 2026.
EarningsLens publishes free AI analysis of every VRTX 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Vertex Pharmaceuticals reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.